Suprarenal Inferior Vena Cava Filters: A 20-Year Single-Center Experience
|
|
- Leslie Parker
- 6 years ago
- Views:
Transcription
1 Suprarenal Inferior Vena Cava Filters: A 20-Year Single-Center Experience 1 Sanjeeva P. Kalva, MD, Chrysanthi Chlapoutaki, MD, Stephan Wicky, MD, Alan J. Greenfield, MD, Arthur C. Waltman, MD, and Christos A. Athanasoulis, MD PURPOSE: To assess the clinical safety and efficacy of suprarenal inferior vena cava (IVC) filters during long-term follow-up. MATERIALS AND METHODS: In this retrospective study, the authors collected the following data about patients who underwent suprarenal IVC filter placement at their institution between 1988 and 2007: demographics, clinical presentation, indications for filter placement, reasons for placing the filter in the suprarenal IVC, type of filter, frequency of pulmonary embolism (PE) after filter placement, and filter-related problems during follow-up. RESULTS: Seventy patients (32 male and 38 female patients; mean age, 60 years) had suprarenal IVC filters. Sixty-two patients presented with symptoms of venous thromboembolism (VTE) and eight had incidental asymptomatic VTE at imaging. Indications for filter placement were as follows: contraindication to anticoagulation n 48), ( complications and/or failure of anticoagulation n ( 12), added protection n ( 8), and prophylaxis n ( 2). Suprarenal placement was chosen due to IVC thrombus n ( 41), intrinsic and/or extrinsic narrowing of the infrarenal IVC n ( 9), renal and/or gonadal vein thrombus n ( 3), congenital IVC anomalies n ( 6), pelvic mass n ( 5), pregnancy (n 3), and other reasons (n 3). The following filters were used: Greenfield n ( 29), Simon Nitinol n ( 5), Vena-Tech (n 3), TrapEase (n 22), OptEase (n 3), Tulip (n 6), Bird s Nest n ( 1), and Recovery n ( 1). During follow-up (mean, 573 days 953), postfilter PE was suspected in 10 patients; eight patients underwent computed tomography (CT), one of whom had PE at CT. None developed new symptoms of caval thrombosis. Abdominal CT (performed in 30 patient at a mean of 543 days 768) showed thrombus in the filter in three patients, fracture in one patient, and penetration of the IVC wall in two patients. CONCLUSIONS: Suprarenal filters are safe and effective in preventing PE. The placement of IVC filters above the renal veins does not carry an added risk of complications. J Vasc Interv Radiol 2008; 19: Abbreviations: DVT deep venous thrombosis, IVC inferior vena cava, PE pulmonary embolism, VTE venous thromboembolism IMPLANTATION of inferior vena tion (1 5). Currently available IVC fil- are approved for placement in theflow). Indications for suprarenal IVC (above the level of renal vein in- cava (IVC) filters is as an alternativeters therapeutic option in patients with ve-infrarenanous thromboembolism (VTE) who however, it may be necessary to im-sic narrowing of the infrarenal IVC IVC. In certain patients, placement include intrinsic or extrin- otherwise cannot receive anticoagulaplant the IVC filter in the suprarenalthat precludes placement of an IVC filter in the infrarenal IVC 6), ( thrombus in the gonadal or renal veins 7 9), ( and anatomic variations of the IVC or From the Department of Radiology, Massachusetts Disclaimer: The abstract has been presented at the the renal veins. Compared with the General Hospital, Harvard Medical School, GRB- Radiological Society of North America Annual infrarenal IVC, the suprarenal IVC is 290, 55 Fruit St, Boston, MA Received November 2, 2007; revision received March 26, 2008; of the data in this paper has been published from Meeting held at Chicago, IL during Nov Some larger in diameter but shorter in accepted March 30, Address correspondence our hospital in various original papers; however, length. Its diameter is variable, often to S.P.K.; skalva@partners.org this paper included more long term follow-up clinical and imaging data whenever available than is right heart pressures. These factors in- 1 Current address: Hopital Armand-Trousseau-La reported in prior papers. influenced by cardiac pulsations and Roche-Guyon, Groupement Hospitalier Universitaire Est, Paris, France. fluence the choice of the filter and the SIR, 2008 risk of incomplete protection (10), filter migration (11), penetration (12), S.W. received honoraria for speaking engagements from Cordis Corporation. DOI: /j.jvir and device fracture. In addition, 1041
2 1042 Suprarenal Inferior Vena Cava Filters July 2008 JVIR thrombus propagation, renal vein thrombosis, and renal failure (13) have been reported with suprarenal IVC filter placement. Original reports by Greenfield et al (6,14) with 148 suprarenal Greenfield IVC filters showed no statistically significant difference in safety and efficacy of suprarenal IVC filters compared with infrarenal IVC filters. A recent study with four different designs of suprarenal IVC filters in 22 patients showed a higher rate of filter migration (15). Athanasoulis et al (16) reported on 44 patients who had filter implantation either in the suprarenal IVC or adjacent to the renal vein inflow and found equal efficacy and safety of these filters compared to traditional infrarenal filters. However, the above studies included only Greenfield-type filters (original 24 F, stainless steel, titanium; Boston Scientific, Natick, Massachusetts), LGM (I and II; B. Braun Medical Inc, Bethlehem, Pennsylvania), and Bird s Nest filters (Cook Medical Inc, Bloomington, Indiana) and the follow-up data were short-term. In this study, we evaluated the safety and efficacy of suprarenal IVC filters of various designs that were placed during a 20- year period in our hospital. MATERIALS AND METHODS This is an institutional review board approved, retrospective study of patients who underwent implantation of an IVC filter above the renal veins at our institution between 1988 and The institutional review board waived the requirement to obtain informed consent from the subjects of this study. The study also complied with the Health Insurance Portability and Accountability Act. Patients Patients who had a suprarenal IVC filter placed at our hospital were identified by using our interventional radiology database system (Hi-IQ System, Health & Inventory Information for Quality, ConexSys, a subsidiary of Society of Interventional Radiology, Woonsocket, Rhode Island) and hospital information system database (Folio views, 4.2, Open Market Inc, Burlington, Massachusetts). During the 20-year period of this review, 4,027 IVC filters were placed Table 1 Underlying Medical Diseases before Filter Placement No. of Patients Underlying Diseases (n 70) Malignancy 39 (56) Perioperative state 9 (13) Congestive heart failure 6 (8.6) Stroke 2 (2.8) Trauma 3 (4.3) Pregnancy 3 (4.3) Other* 8 (11) Note. Numbers in parentheses are percentages. * Other includes hypercoagulable states in two patients, heparin-induced thrombocytopenia in one patient, systemic lupus erythematosis with antiphospholipid antibodies in one patient, nephrolithiasis in one patient, nephrotic syndrome in one patient, pancreatitis in one patient, and leg ulcer in one patient. at our institution. Seventy patients had a suprarenal IVC filter. There were 32 male (46%) and 38 female (54%) patients. The age of the patients at filter implantation ranged from 16 to 94 years, with a mean of 60 years and median of 58 years. The male patients ranged in age from 19 to 87 years (mean age, 62 years; median age, 67 years). The female patients ranged in age from 16 to 94 years (mean age, 57 years; median age, 56 years). Clinical and Procedural Data The following preprocedural clinical details were recorded: clinical presentation at the time of filter request, underlying medical condition, imaging findings with regard to VTE at filter request, and indications for filter placement. Technical details of filter implantation including the route of venous access, findings at cavography, type of filter used, reasons for suprarenal filter placement, and complications during filter implantation were recorded. Clinical Presentation Thirty-five of the 70 patients (50%) presented with clinical symptoms and signs of deep venous thrombosis (DVT). Twenty-seven patients (38%) presented with clinical symptoms and signs of PE. The remaining eight patients (11%) had no signs or symptoms of VTE. In these eight patients, VTE was found incidentally on imaging studies obtained for some other reason and patients were referred for IVC filter placement. Table 1 lists the underlying medical conditions in all patients before filter placement. Indications for Filter Placement A contraindication to anticoagulation in the presence of VTE constituted the major indication for filter placement. Forty-eight of the 70 patients (68%) had a contraindication to anticoagulation. The contraindications included the presence of brain malignancy (n 7); other intracranial abnormality (stroke in three, intracranial bleed in three); active bleeding (gastrointestinal bleeding in four, hematuria in three); cancers with an active or with a high potential for bleeding (endometrial cancer in four, gastric cancer in two, anal cancer in one, and retroperitoneal cancer in one); perioperative state after abdominal/pelvic surgery (n 10), chest surgery (n 3), or orthopedic surgery (n 3); and others, septicemia in one, retroperitoneal tumor compressing the IVC in two, risk of fall in one). Five of the 70 patients (7.1%) had developed bleeding complications (rectus sheath hematoma in one [a pregnant patient], retroperitoneal hematoma in one, hematuria in one, subdural hematoma in one, and vaginal bleeding in one) after anticoagulation. Seven of the 70 patients (10%) had failure of anticoagulation with recurrent VTE despite use of anticoagulants. In eight patients (11%), a filter was implanted as an additional protection in addition to
3 Volume 19 Number 7 Kalva et al 1043 anticoagulation due to the presence of underlying cardiac disease or right heart strain. In two patients (2.8%), the filter was prophylactic one was placed preoperatively in a patient with ovarian cancer and the other was placed in a patient with multiorgan trauma. Filter Implantation Although a defined standard protocol has not been in place, a practice pattern described herein has been followed by almost all operators. Access to the IVC was obtained through the right common femoral vein in 48 of the 70 patients (68%), left femoral vein in seven patients (10%), right internal jugular vein in 14 patients (20%), and right basilic vein in one patient (1.4%). A pigtail catheter was placed in the IVC just above the iliac vein confluence and cavography performed. The pigtail catheter was exchanged over a wire for the filter delivery sheath, and the filter was deployed according to the manufacturer s guidelines. Repeat cavography was performed after filter implantation. Follow-up Clinical and imaging follow-up data were recorded whenever available. The concurrent use of anticoagulants after filter placement was recorded. However, the concurrent use of antiplatelet agents was not recorded. Immediate and long-term complications were reviewed. The occurrence of PE and symptomatic vena cava thrombosis after filter placement were recorded during clinical followup. Whenever postfilter PE was suspected clinically, the available imaging data including images from computed tomographic (CT) pulmonary angiography or ventilation-perfusion scintigraphy were reviewed for evidence of PE. If any patient underwent abdominal CT for any reason during follow-up, the scan was reviewed for filter migration (of 2 cm), filter fracture, migration of fractured fragments, thrombus in the filter or the IVC, and penetration of more than 3 mm through the wall of the IVC. Similarly, if any patient underwent contrast medium enhanced chest CT for any clinical reason, the CT scan was reviewed for PE. Imaging studies (ultrasonography [US] and CT venography) obtained for lower extremity DVT after filter placement were reviewed for the occurrence of new DVT. Endpoints The safety of suprarenal filters was assessed on the basis of the occurrence of symptomatic or asymptomatic problems such as vena cava thrombosis, filter migration, and device fracture during filter deployment and follow-up. The efficacy was assessed on the basis of the occurrence of fatal and nonfatal PE after filter placement. RESULTS Imaging for VTE before Filter Implantation Sixty-seven of the 70 patients (96%) were tested for VTE before filter implantation. Sixty-six of the 67 patients had VTE on imaging studies. Ten patients had both PE and DVT, 40 had DVT, and 16 had PE. One patient had no VTE at imaging. A filter was requested in this patient for prophylaxis after major trauma. Twenty-nine patients were tested for PE. CT pulmonary angiography was performed in 18 patients, conventional catheter pulmonary angiography in nine, and ventilation-perfusion scanning in two. Of the 29 patients tested for PE, 26 had PE at imaging. Fifty-nine patients were tested for DVT. Compression color Doppler US was performed in 28 patients, CT in 24, conventional venography in four, and magnetic resonance imaging in three. Of the 59 patients tested for DVT, 50 had DVT at imaging. DVT affected the left leg in 16 patients, the right leg in 13, and both legs in 13. Thrombus in the IVC was seen in six patients, including one who had additional left renal vein thrombus. One patient had left renal vein thrombus, and one additional patient had left gonadal vein thrombus. Three patients had no imaging studies prior to filter requests. One patient was on warfarin sodium (Coumadin; Bristol-Myers Squibb Co, Princeton, New Jersey) for prior PE and had clinical symptoms of recurrent PE when the filter was requested. Another patient had left renal vein thrombosis on a prior abdominal CT scan, with an underlying renal cell cancer and brain metastases. The third patient had ovarian cancer, and a filter was requested preoperatively as a prophylactic measure against PE. Findings at Cavography Cavography demonstrated thrombus in the IVC in 33 patients. Thrombus was below the renal veins in 32 patients and extended into the suprarenal IVC in one patient. One of the 33 patients also had diffuse narrowing of the infrarenal IVC, which was probably due to chronic thrombosis. Nine additional patients had thrombus in the infrarenal IVC that extended above an existing infrarenal IVC filter. Thus, overall, thrombus in the IVC was found in 42 patients. Chronic occlusion with narrowing of the IVC and retroperitoneal collateral vessels was found in three patients. One additional patient had diffuse narrowing of the infrarenal IVC with no documented collateral vessels. Two patients had renal vein thrombosis. Four patients had extrinsic compression of the infrarenal IVC. Developmental anomalies of the IVC and renal veins were found in seven patients, including a duplicated IVC in four patients, circumaortic left renal vein in two patients, and retroaortic left renal vein in one patient. Eleven patients had a normal, patent IVC. In these 11 patients, the suprarenal IVC was chosen for filter placement due to a pelvic and/or abdominal mass necessitating surgery, pregnancy, or renal/gonadal vein thrombosis. Suprarenal Placement Reasons for placing the filter above the renal veins are listed in Table 2. Acute or chronic thrombosis of the infrarenal IVC was the major reason for choosing suprarenal implantation. The second most common reason was developmental anomalies of the IVC and renal veins. Filters used in this study are listed in Table 3. The filters were successfully deployed at the intended location in all but one patient, in whom the filter migrated to the heart immediately after deployment (see the next section).
4 1044 Suprarenal Inferior Vena Cava Filters July 2008 JVIR Table 2 Reasons for Choosing Suprarenal IVC for Filter Implantation No. of Patients Reason (n 70) Thrombus in IVC 41 (58) Extrinsic compression 4 (5.7) Duplication 4 (5.7) Circumaortic renal vein 2 (2.9) Surgery* 1 (1.4) Pregnancy 3 (4.3) Pelvic mass necessitating surgery 5 (7.1) Chronic occlusion/intrinsic narrowing 5 (7.1) Technical 2 (2.9) Renal vein thrombus 2 (2.9) Gonadal vein thrombus 1 (1.4) Note. Numbers in parentheses are percentages. * Surgery was performed for an adrenal mass. One patient also had infrarenal IVC thrombus. Table 3 Filters Used in this Study Filters Used No. of Patients 12-F titanium Greenfield 23 (33) 12-F Greenfield (unspecified) 3 (4.3) 12-F stainless steel Greenfield 2 (2.9) 24-F Greenfield 1 (1.4) Vena Tech (LGM) 3 (4.3) Simon Nitinol 5 (7.1) Bird s Nest 1 (1.4) TrapEase 22 (31.4) OptEase 3 (4.3) Recovery 1 (1.4) Tulip 6 (8.6) Immediate Complications In four patients, there was a problem during deployment of the 12-F Titanium Greenfield filter. The filter legs did not open properly during deployment, and they were clumped together. This required additional maneuvers with a catheter to open the legs. During deployment of a Titanium Greenfield filter in another patient, one of the filter legs landed in the renal vein. Thrombus within the IVC migrated to the apex of the filter (Greenfield filter, unspecified) just after filter deployment in another patient. One filter (Simon Nitinol filter) migrated to the heart during deployment and was later retrieved with an endovascular approach with no further complications. Later, a suprarenal titanium Greenfield filter was placed in that patient. One Tulip filter required repositioning immediately after deployment due to incomplete opening of the filter in a patient with thrombus in the suprarenal IVC (Figure). Subsequent Interventional Procedures In one patient with IVC narrowing, a stent was placed in the IVC after filter deployment. Another patient who had presented with extensive DVT underwent thrombolysis and stent placement of the IVC and iliac veins just after filter deployment. Another patient received bilateral iliac vein stents to relieve extrinsic compression by a large endometrial cancer. One OptEase filter was successfully retrieved 6 days after placement. In another patient, a Tulip filter was successfully retrieved 79 days after placement. Clinical Follow-up Clinical follow-up was available in 61 of the 70 patients (87%). The follow-up period ranged from 2 to 3,933 days, with a mean ( standard deviation) and median follow-up of 573 days 953 and 137 days, respectively. During the follow-up, 23 of the 61 patients (38%) received anticoagulation (including heparin or low-molecularweight heparin in 10 patients and warfarin sodium in 13). Fifteen patients died during follow-up (range, 2 1,229 days; mean, 195 days 328; median, 52 days). Seven of the 61 patients (11%) died within 30 days of filter placement. An autopsy was performed in three patients. In one patient, there was no PE. One patient demonstrated multiple septic emboli in both lungs, which were seen on the CT pulmonary angiogram obtained before filter placement. Disseminated intravascular coagulation was considered to be the cause of death in this patient. Another patient had chronic PE, which were demonstrated with catheter pulmonary angiography before filter placement. There were no deaths due to PE. Late Complications During follow-up, 10 of 61 patients had symptoms and signs of PE, including one patient who had two episodes. The first episode of postfilter PE was suspected clinically after a median of 149 days (range, 1 1,147 days; mean, 340 days 403) after filter placement. Two patients had PE within the first 10 days after filter placement. Eight of the 10 patients were evaluated with CT pulmonary angiography; one had a new PE at CT. One additional patient underwent ventilation-perfusion scanning and was found to have low probability for PE. The other patient had no imaging studies. Thus, overall, the frequency of postfilter clinical PE was 11.5% (10 of 61). However, PE was confirmed with imaging only in one of the 61 patients (16%). During follow-up, none of the patients had new symptoms suggestive of IVC thrombosis or occlusion. Laboratory results of renal function were available in 65 patients after a median of 54 days (range, 1 3,656 days; mean, 543 days 947) after filter placement.
5 Volume 19 Number 7 Kalva et al 1045 Figure. Cavograms in an 80-year-old woman who was being treated with warfarin sodium for thrombus in the suprarenal IVC. The patient presented with gastrointestinal bleeding. An IVC filter was requested in view of complication from warfarin sodium therapy. (a) Image obtained through a pigtail catheter placed in the infrarenal IVC demonstrates thrombus (arrow) in the suprarenal IVC. (b) A Tulip filter was deployed; however, the legs (arrow) were deployed partially in the thrombus and the filter did not open completely. (c) The filter was retrieved and redeployed at a higher location above the thrombus. Seven of the 65 patients (11%) had worsening renal function, which occurred within a mean of 36 days 47 (range, days; median, 26 days) after filter placement. In three patients, the worsening renal function was attributed to bilateral obstructive hydronephrosis from prostate cancer (n 2) or recurrent rectal cancer (n 1). Renal failure was attributed to multiorgan failure after major hepatic resection in one patient and to septicemia with candida infection in one patient. One patient developed acute renal failure 4 weeks after filter placement, and US demonstrated patent renal veins. One patient had mild worsening of renal function, and no follow-up data were available. Imaging Follow-up Abdominal CT. After filter placement, 30 of the 70 patients (43%) underwent abdominal CT. CT was performed for various clinical reasons pertinent to the underlying medical disease and not for the IVC filter per se. CT was performed at a mean and median of 543 days 768 and 272 days, respectively, after filter placement (range, 6 2,621 days). Thrombus within the filter was noted in three filters two TrapEase and one Tulip. Thrombus was seen in the periphery of the TrapEase filter as a thin rim attached to the wall of the IVC. In the case of the Tulip filter, the thrombus was seen at the apex of the filter, without total occlusion of the IVC. There were no cases of filter migration of more than 2 cm; however, one Tulip filter migrated 1 cm superiorly. Two filters (one Recovery and one Greenfield, material unspecified) penetrated the caval wall and the filter legs were seen in the pancreas or the liver. In one patient, one of the legs of the titanium Greenfield filter was in the renal vein. Another patient with a titanium Greenfield filter developed new thrombus in the IVC without any filter thrombus. There was no extension of the thrombus into the renal veins in any patient. Chest CT. Chest CT scans obtained after filter placement were available in 17 of the 70 patients (24%). Chest CT was performed at a mean and median of 595 days 759 and 312 days, respectively, after filter placement (range, 1 2,367 days). In eight patients, CT was performed for suspected PE according to a standard thin-section ( mmthick sections) CT pulmonary angiography protocol. In the remaining nine patients, chest CT was performed for lung disease with use of 5-mm-thick sections. There was no asymptomatic PE at chest CT. As described earlier, one of the symptomatic patients had new PE at CT. Imaging for DVT. After filter placement, 13 patients underwent imaging of the lower extremities for clinically suspected PE or DVT. These imaging studies were obtained at a mean and median of 350 days 483 and 137 days, respectively, after filter placement (range, 10
6 1046 Suprarenal Inferior Vena Cava Filters July 2008 JVIR 1,606 days). Eight of the 13 patients underwent compression color Doppler US and five underwent CT venography. New DVT was seen in one patient, affecting the popliteal vein. One additional patient had thrombosis of an iliac vein stent that was placed to relieve extrinsic compression. DISCUSSION Before the introduction of IVC filters, surgical cava ligation or plication (17,18) were performed to protect patients from potentially lethal PE if these patients could not receive anticoagulants. Surgery was directed to the infrarenal IVC to avoid renal vein thrombotic occlusion. IVC filters were developed as an alternative to surgery. Therefore, they were designed for placement in the infrarenal IVC. The first-generation IVC filters were associated with a high incidence of caval thrombosis (19 21). Thus, application of filters was strictly limited to placement in the infrarenal position. An additional recommendation was to place the device with its apex near the point where the renal veins drain into the cava. Renal venous inflow would prevent propagation of thrombus above the filter in case of filter thrombosis. This practice continues today. Filter implantation in the infrarenal IVC has been the norm due to persistent concerns about suprarenal filter position. All currently available IVC filters are approved for implantation in the infrarenal IVC. However, implantation in the suprarenal IVC was described as early as 1981 by Greenfield (22). Other early reports (6,8,14,23) on suprarenal implantation of the Greenfield filter demonstrated no problems or additional complications as a result of placement above the renal veins. There have been sporadic case reports published about perforation, penetration, and migration of the suprarenal Greenfield filter (12,24,25). A more recent publication on suprarenal filters by Matchett et al (15) in 22 patients reported the use of four different types (titanium Greenfield filter, Vena Tech LGM 1& 2, Bird s Nest filter). They reported high efficacy and a 3% rate of migration with suprarenal filters. Thrombus propagation and renal dysfunction, reported in one article (13), have not been observed in other studies. Although these studies suggested the safety of suprarenal filter placement, they were confined predominantly to the Greenfield filter design. Many new devices have been approved since then, and they are used more often than the Greenfield filter due to the small size of the delivery system. The safety and efficacy of these filters have not been reported. In addition, we report CT imaging follow-up in almost half of our patients to look for asymptomatic filter-related problems. In agreement with previous reports, we found high efficacy of suprarenal IVC filters. The overall frequency of clinical PE was 11.5% and that of imaging-evident PE was 16%, which is comparable to that reported with infrarenal IVC filters (4,16,26 28). The occurrence of new, symptomatic caval thrombosis after filter placement was rare. The concurrent use of anticoagulants as clinically appropriate may also have contributed to the low occurrence of PE and symptomatic vena caval thrombosis. Other complications, such as penetration or perforation, were found in two patients at CT but were asymptomatic. Except for migration of a Simon Nitinol filter to the heart, procedural problems were predominantly due to incomplete opening of the Greenfield filter. Migration of a filter is affected by many factors, such as the diameter of the IVC at filter placement, changes in the diameter immediately after filter placement, filter design, and operator errors. The diameter of the suprarenal IVC is larger than that of the infrarenal IVC. In addition, the diameter of the IVC is related to venous return (29), blood volume (30), and respiratory cycle. These factors are important when choosing the type of filter design for implantation in the suprarenal IVC. A few filters (Greenfield, Simon Nitinol, Vena Tech, G2) are approved for an IVC of 28 mm in diameter, whereas other filters (TrapEase, OptEase, Tulip) are approved for an IVC of 30 mm. The Bird s Nest filter is approved for placement in a mega cava, up to a diameter of 40 mm. A correct assessment of IVC diameter is essential so that an appropriate filter can be chosen. Renal dysfunction, although a concern if thrombus extends into the renal vein, is uncommon after suprarenal IVC filter placement. Extension of the thrombus into the renal veins is more common in the presence of extensive thrombus in the infrarenal IVC and absence of therapy with anticoagulants. Previous studies (8,14) have shown no incidence of renal dysfunction after filter placement in the suprarenal IVC. In our study, there was no CT evidence of thrombus propagation to the renal veins after suprarenal IVC filter placement. Although seven patients developed renal dysfunction after filter placement, underlying medical conditions contributed to renal dysfunction in five patients. US showed patent renal veins in one additional patient with acute renal failure 1 month after filter placement. This study is limited because it is retrospective, based on a review of medical records. No standard protocol was followed for filter placement, as the devices and operator changed during the study period. There was no complete follow-up and no standardized follow-up imaging in all patients. However, it provides additional information about the feasibility of placing IVC filters in the cava above the renal veins in the clinical circumstances when this becomes necessary. In conclusion, we have found that if placement of IVC filters in the infrarenal cava is not feasible, placement above the renal veins may be considered. The efficacy and safety of suprarenal IVC filters is comparable to that of filters placed in the standard, below-the renal veins position. References 1. Jacobs DG, Sing RF. The role of vena caval filters in the management of venous thromboembolism. Am Surg 2003; 69: Rectenwald JE. Vena cava filters: uses and abuses. Semin Vasc Surg 2005; 18: Moores LK, Tapson VF. Vena caval filters in pulmonary embolism. Semin Vasc Med 2001; 1: Kinney TB. Update on inferior vena cava filters. J Vasc Interv Radiol 2003; 14: Weichman K, Ansell JE. Inferior vena cava filters in venous thromboembolism. Prog Cardiovasc Dis 2006; 49: Greenfield LJ, Proctor MC. Suprarenal filter placement. J Vasc Surg 1998; 28: , discussion Abujudeh H, Lim H. Emergency suprarenal inferior vena cava filter place-
7 Volume 19 Number 7 Kalva et al 1047 ment in ovarian vein thrombosis. Emerg Radiol 2004; 10: Orsini RA, Jarrell BE. Suprarenal placement of vena caval filters: indications, techniques, and results. J Vasc Surg 1984; 1: Wieland A, Mehta A, Greenfield A, Wolf M. Temporary suprarenal inferior vena cava filter for renal biopsy in a patient with renal vein thrombosis. Clin Nephrol 2004; 62: Lemmon GW, Litscher LJ. Incomplete caval protection following suprarenal caval filter placement: a case report. Angiology 2000; 51: Ganguli S, Tham JC, Komlos F, Rabkin DJ. Fracture and migration of a suprarenal inferior vena cava filter in a pregnant patient. J Vasc Interv Radiol 2006; 17: Teitelbaum GP. Perforation of the inferior vena cava by a suprarenal Greenfield filter. Radiology 1990; 174: Marcy PY, Magne N, Frenay M, Bruneton JN. Renal failure secondary to thrombotic complications of suprarenal inferior vena cava filter in cancer patients. Cardiovasc Intervent Radiol 2001; 24: Greenfield LJ, Cho KJ, Proctor MC, Sobel M, Shah S, Wingo J. Late results of suprarenal Greenfield vena cava filter placement. Arch Surg 1992; 127: Matchett WJ, Jones MP, McFarland DR, Ferris EJ. Suprarenal vena caval filter placement: follow-up of four filter types in 22 patients. J Vasc Interv Radiol 1998; 9: Athanasoulis CA, Kaufman JA, Halpern EF, Waltman AC, Geller SC, Fan CM. Inferior vena caval filters: review of a 26-year single-center clinical experience. Radiology 2000; 216: Spencer FC, Quattlebaum JK, Quattlebaum JK Jr, Sharp EH, Jude JR. Plication of the inferior vena cava for pulmonary embolism: a report of 20 cases. Ann Surg 1962; 155: Pollak EW, Sparks FC, Barker WF. Inferior vena cava interruption: indications and results with caval ligation, clips and intracaval devices in 110 cases. J Cardiovasc Surg (Torino) 1974; 15: Wingerd M, Bernhard VM, Maddison F, Towne JB. Comparison of caval filters in the management of venous thromboembolism. Arch Surg 1978; 113: Ferris EJ, McCowan TC, Carver DK, McFarland DR. Percutaneous inferior vena caval filters: follow-up of seven designs in 320 patients. Radiology 1993; 188: Menzoian JO, LoGerfo FW, Weitzman AF, Ezpeleta M, Sequeira JC. Clinical experience with the Mobin-Uddin vena cava umbrella filter. Arch Surg 1980; 115: Greenfield LJ, Peyton R, Crute S, Barnes R. Greenfield vena caval filter experience: late results in 156 patients. Arch Surg 1981; 116: Stewart JR, Peyton JW, Crute SL, Greenfield LJ. Clinical results of suprarenal placement of the Greenfield vena cava filter. Surgery 1982; 92: Kim D, Porter DH, Siegel JB, Simon M. Perforation of the inferior vena cava with aortic and vertebral penetration by a suprarenal Greenfield filter. Radiology 1989; 172: Greenfield LJ. Perforation of the inferior vena cava with aortic and vertebral penetration by a suprarenal Greenfield filter. Radiology 1990; 175: Liu WC, Do YS, Choo SW, et al. The mid-term efficacy and safety of a permanent nitinol IVC filter (TrapEase). Korean J Radiol 2005; 6: Kalva SP, Wicky S, Waltman AC, Athanasoulis CA. TrapEase vena cava filter: experience in 751 patients. J Endovasc Ther 2006; 13: Kalva SP, Athanasoulis CA, Fan CM, et al. Recovery vena cava filter: experience in 96 patients. Cardiovasc Intervent Radiol 2006; 29: Lorsomradee S, Lorsomradee S, Cromheecke S, ten Broecke PW, De Hert SG. Inferior vena cava diameter and central venous pressure correlation during cardiac surgery. J Cardiothorac Vasc Anesth 2007; 21: Chen L, Kim Y, Santucci KA. Use of ultrasound measurement of the inferior vena cava diameter as an objective tool in the assessment of children with clinical dehydration. Acad Emerg Med 2007; 14:
Inferior Venacaval Filters Valuable vs. Dangerous Valuable Annie Kulungowski. Department of Surgery Grand Rounds March 24, 2008
Inferior Venacaval Filters Valuable vs. Dangerous Valuable Annie Kulungowski Department of Surgery Grand Rounds March 24, 2008 History of Vena Cava Filters Virchow-1846-Proposes PE originate from veins
More informationIVC Filters: For Whom, Why and When?
IVC Filters: For Whom, Why and When? Dariusz Zawierucha, MD Interventional & Diagnostic Radiology Radiology Associates, PC 1 Disclosures: I have no financial conflicts to disclose. I do not endorse any
More informationClinical Guide - Inferior Vena Cava Filters (Reviewed 2006)
Clinical Guide - Inferior Vena Cava Filters (Reviewed 2006) Principal Developer: V. Oliva Secondary Developers: W. Geerts Background The treatment of choice for deep venous thrombosis (DVT) and pulmonary
More informationSpontaneous Tilting after Placement of the Gu nther-tulip Inferior Vena Caval Filter: A Case Report 1
Spontaneous Tilting after Placement of the Gu nther-tulip Inferior Vena Caval Filter: Case Report 1 Tae-Seok Seo, M.D., In-Ho Cha, M.D., Hae Young Seol, M.D., Cheol Min Park, M.D. Tilting of a deployed
More informationINFERIOR VENA CAVA FILTERS QUIZ 10 QUESTIONS MAY 5, 2014
INFERIOR VENA CAVA FILTERS QUIZ 10 QUESTIONS MAY 5, 2014 QUESTION 1 1. Anatomically Transposition of the IVC is observed in what % of individuals A) 1-5% B).2-.05% C) 3-5% D) 5-10% ANSWER QUESTION 1 Answer
More informationPREVENTION AND TREATMENT OF VENOUS THROMBOEMBOLISM
PREVENTION AND TREATMENT OF VENOUS THROMBOEMBOLISM International Consensus Statement 2013 Guidelines According to Scientific Evidence Developed under the auspices of the: Cardiovascular Disease Educational
More informationIVC Filters: Rate of Insertion, Indications, Effects on Prognosis, Evidence Basis for Current Practices. Paul D. Stein, MD
IVC Filters: Rate of Insertion, Indications, Effects on Prognosis, Evidence Basis for Current Practices Paul D. Stein, MD Professor Department of Osteopathic Medical Specialties College of Osteopathic
More informationI am NOT: Disclosures. The Problem of the Con-Position Non Thinking! Against New Ideas. Against New Therapies. Against Endovascular Therapies
Inferior Vena Cava Filters: Disclosures A Love /Hate (Mostly Hate) Relationship Lack of Political Correctness Gregory L. Moneta, M.D. Professor and Chief, Vascular Surgery Oregon Health & Science University
More informationDeep Venous Thrombosis, Pulmonary Embolus and IVC Filters. Michael Meuse, M.D. Vascular and Interventional Radiology
Deep Venous Thrombosis, Pulmonary Embolus and IVC Filters Michael Meuse, M.D. Vascular and Interventional Radiology Pulmonary Embolism and DVT Estimated 570,000 to 650,000 cases of symptomatic PE each
More informationInferior Vena Cava Filters- Are they Followed up? By Dr Nathalie van Havre Dr Chamica Wijesinghe Dr Kieren Brown
Inferior Vena Cava Filters- Are they Followed up? By Dr Nathalie van Havre Dr Chamica Wijesinghe Dr Kieren Brown Introduction Trousseau (1868) first described interruption to inferior vena cava (IVC) to
More informationCase Report Aspiration Thrombectomy in a Patient with Suprarenal Inferior Vena Cava Thrombosis
Case Reports in Cardiology Volume 2015, Article ID 495065, 4 pages http://dx.doi.org/10.1155/2015/495065 Case Report Aspiration Thrombectomy in a Patient with Suprarenal Inferior Vena Cava Thrombosis Hideyuki
More informationInferior Vena Cava Filter Retrieval
Inferior Vena Cava Filter Retrieval Tips on the best methods for retrieving an IVC filter. BY THUONG G. VAN HA, MD Studies have shown that inferior vena cava (IVC) filters are effective in the prevention
More informationComplications of Inferior Vena Caval Filters
Complications of Inferior Vena Caval Filters Thuong G. Van Ha, M.D. 1 ABSTRACT Inferior vena caval filters have been shown to be effective in the prevention of pulmonary embolism, with low morbidity and
More informationInterventional Treatment VTE: Radiologic Approach
Interventional Treatment VTE: Radiologic Approach Hae Giu Lee, MD Professor, Dept of Radiology Seoul St. Mary s Hospital The Catholic University of Korea Introduction Incidence High incidence: 250,000-1,000,000/year
More informationSupplementary Online Content
Supplementary Online Content Mismetti P, Laporte S, Pellerin O, Ennezat P-V, Couturaud F, Elias A, et al. Effect of a retrievable inferior vena cava filter plus anticoagulation vs anticoagulation alone
More informationPerforated inferior vena cava filter removal by concurrent femoral and internal jugular vein approaches
www.edoriumjournals.com CLINICAL IMAGES PEER REVIEWED OPEN ACCESS Perforated inferior vena cava filter removal by concurrent femoral and internal jugular vein approaches Raymond Yap, Ankur Sidhu, Mark
More informationJ Jpn Coll Angiol, 2009, 49:
Online publication August 27, 2009 1 2 J Jpn Coll Angiol, 2009, 49: 247 254 deep vein thrombosis, thrombolytic therapy, catheter-directed thrombolysis, inferior vena cava filter, pulmonary thromboembolism
More informationIVC FILTERS: A CASE REPORT REVIEWING THE INDICATIONS FOR PLACEMENT, RETRIEVAL AND ANTICOAGULATION
IVC FILTERS: A CASE REPORT REVIEWING THE INDICATIONS FOR PLACEMENT, RETRIEVAL AND ANTICOAGULATION Resident(s): George Athanasatos Attending(s): Daniel Golwyn Program/Dept: Interventional Radiology CHIEF
More informationOptimal Filter Placement
Obtaining Optimal Filter Placement How imaging and technical skill ensure safe placement of an IVC filter. BY MARK W. BURKET, MD When compared to many other endovascular procedures, placement of an inferior
More informationIntervention for Deep Venous Thrombosis and Pulmonary Embolus
Intervention for Deep Venous Thrombosis and Pulmonary Embolus Michael R. Jaff, DO Paul and Phyllis Fireman Endowed Chair in Vascular Medicine Massachusetts General Hospital Professor of Medicine Harvard
More informationCURRENT & FUTURE THERAPEUTIC MANAGEMENT OF VENOUS THROMBOEMBOLISM. Gordon Lowe Professor of Vascular Medicine University of Glasgow
CURRENT & FUTURE THERAPEUTIC MANAGEMENT OF VENOUS THROMBOEMBOLISM Gordon Lowe Professor of Vascular Medicine University of Glasgow VENOUS THROMBOEMBOLISM Common cause of death and disability 50% hospital-acquired
More informationOn Which Criteria Do You Select Your Stent for Ilio-femoral Venous Obstruction? North American Point of View
On Which Criteria Do You Select Your Stent for Ilio-femoral Venous Obstruction? North American Point of View Peter Gloviczki, MD Ying Huang, MD, PhD Division of Vascular and Endovascular Surgery, Mayo
More informationBard Meridian Filter Fracture
Bard Meridian Filter Fracture The MIT Faculty has made this article openly available. Please share how this access benefits you. Your story matters. Citation As Published Publisher Wu, Alex et al. Bard
More informationInferior Vena Cava Filters
Inferior Vena Cava Filters and the American Society of Hematology Choosing Wisely Campaign Kevin P. Hubbard, DO, HMDC MACOI Chief - Division of Specialty Medicine Professor and Chair - Section of Internal
More informationDr. Rami M. Adil Al-Hayali Assistant Professor in Medicine
Dr. Rami M. Adil Al-Hayali Assistant Professor in Medicine Venous thromboembolism: pulmonary embolism (PE) deep vein thrombosis (DVT) 1% of all patients admitted to hospital 5% of in-hospital mortality
More informationEndovascular treatment of acquired arteriovenous fistula with severe hemodynamic effects: a case report
Endovascular treatment of acquired arteriovenous fistula with severe hemodynamic effects: a case report The Leipzig Interventional Course, January 24 27, 2017 El Samman K., Šedivý P., Šnajdrová A., Přindišová
More informationImaging, it s central role in planning and guiding intervention. Prof. Luis Izquierdo. MD, PhD, FEBVS
Imaging, it s central role in planning and guiding intervention Prof. Luis Izquierdo. MD, PhD, FEBVS IMPORTANT INFORMATION: These materials are intended to describe common clinical considerations and procedural
More informationB. Tardy*, P. Mismetti**, Y. Page*, H. Décousus**, A. Da Costa +, F. Zeni*, G. Barral ++, J.C. Bertrand*
Eur Respir J, 1996, 9, 2012 2016 DOI: 10.1183/09031936.96.09102012 Printed in UK - all rights reserved Copyright ERS Journals Ltd 1996 European Respiratory Journal ISSN 0903-1936 clin- Symptomatic inferior
More informationSample page. POWER UP YOUR CODING with Optum360, your trusted coding partner for 32 years. Visit optum360coding.com.
2018 Complete Guide for Interventional Radiology An in-depth guide to interventional radiology coding, billing, and reimbursement for facilities and physicians POWER UP YOUR CODING with Optum360, your
More informationSurgical approach for DVT. Division of Vascular Surgery Department of Surgery Seoul National University College of Medicine
Surgical approach for DVT Seung-Kee Min Division of Vascular Surgery Department of Surgery Seoul National University College of Medicine Treatment Options for Venous Thrombosis Unfractionated heparin &
More informationDisclosures. DVT: Diagnosis and Treatment. Questions To Ask. Dr. Susanna Shin - DVT: Diagnosis and Treatment. Acute Venous Thromboembolism (VTE) None
Disclosures DVT: Diagnosis and Treatment None Susanna Shin, MD, FACS Assistant Professor University of Washington Acute Venous Thromboembolism (VTE) Deep Venous Thrombosis (DVT) Pulmonary Embolism (PE)
More informationVTE in the Trauma Population
VTE in the Trauma Population Erik Peltz, D.O. February 11 th, 2015 * contributions from Eduardo Gonzalez, M.D. University of Colorado T-32 Research Fellow The problem. VTE - Scope of the Problem One of
More informationDivision of Vascular Surgery, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, 2
Vascular Specialist International Vol. 34, No. 4, December 2018 pissn 2288-7970 eissn 2288-7989 Clinical Outcomes of a Preoperative Inferior Vena Cava Filter in Acute Venous Thromboembolism Patients Undergoing
More informationHow to best approach chronic venous occlusions?
How to best approach chronic venous occlusions? Prof. Nils Kucher Director Venous Thromboembolism Reseach Group University Hospital Bern nilskucher.com Disclosure Speaker name: Nils Kucher X X I have the
More informationTHROMBOEMBOLIC EVENTS AFTER IVC FILTER PLACEMENT IN TRAUMA PATIENTS. Lidie Lajoie, MD SUNY Downstate Department of Surgery December 20, 2012
THROMBOEMBOLIC EVENTS AFTER IVC FILTER PLACEMENT IN TRAUMA PATIENTS Lidie Lajoie, MD SUNY Downstate Department of Surgery December 20, 2012 Background Trauma Patients at High Risk for VTE Spain, D.A.,
More informationwith Vena Caval Umbrella
Prevention of Pulmonary Embolus with Vena Caval Umbrella Results in 150 Patients Thomas 0. Orvald, M.D., George M. Callard, M.D., and James R. Jude, M.D. ABSTRACT A simple technique for effectively interrupting
More informationM Johnson Disclosures
2/22/2013 IVC Filters: Current Controversies and the PRESERVE Study Matthew S Johnson MD FSIR Indiana University School of Medicine M Johnson Disclosures Speaking and Teaching Bayer Cook Nordion Research
More informationInterventional Radiology in Trauma. Vikash Prasad, MD, FRCPC Vascular and Interventional Radiology The Moncton Hospital
Interventional Radiology in Trauma Vikash Prasad, MD, FRCPC Vascular and Interventional Radiology The Moncton Hospital Disclosures None relevant to this presentation Shareholder Johnson and Johnson Goal
More informationPictorial review of IVC filters and their complications
Pictorial review of IVC filters and their complications Poster No.: C-1353 Congress: ECR 2014 Type: Educational Exhibit Authors: J. A. Vossen, J. S. Golia, L. Miller, D. Fedele, N. Velasco; Bridgeport,
More informationPREVENTION AND TREATMENT OF VENOUS THROMBOEMBOLISM
PREVENTION AND TREATMENT OF VENOUS THROMBOEMBOLISM International Consensus Statement 2013 Guidelines According to Scientific Evidence Developed under the auspices of the: Cardiovascular Disease Educational
More informationUnderstanding of the importance of venous
The Critical Need for an Iliofemoral Venous Obstruction Classification System An overview of a potential classification system to better identify and treat iliofemoral venous outflow obstruction. BY WILLIAM
More informationPenetration of Celect Inferior Vena Cava Filters: Retrospective Review of CT Scans in 265 Patients
Vascular and Interventional Radiology Original Research Zhou et al. CT of Celect Inferior Vena Cava Filter Penetration Vascular and Interventional Radiology Original Research Dayong Zhou 1,2 Eunice Moon
More informationExpanding Horizons: AngioVac Suction Thrombectomy at UTHealth
Expanding Horizons: AngioVac Suction Thrombectomy at UTHealth Naveed Saqib, MD Assistant Professor Department of Cardiothoracic and Vascular Surgery McGovern Medical School The University of Texas Science
More informationBard Recovery Filter: Evaluation and Management of Vena Cava Limb Perforation, Fracture, and Migration
Bard Recovery Filter: Evaluation and Management of Vena Cava Limb Perforation, Fracture, and Migration Jeffrey E. Hull, MD, and Scott W. Robertson, PhD PURPOSE: To report on the evaluation and management
More informationBC Vascular Day. Contents. November 3, Abdominal Aortic Aneurysm 2 3. Peripheral Arterial Disease 4 6. Deep Venous Thrombosis 7 8
BC Vascular Day Contents Abdominal Aortic Aneurysm 2 3 November 3, 2018 Peripheral Arterial Disease 4 6 Deep Venous Thrombosis 7 8 Abdominal Aortic Aneurysm Conservative Management Risk factor modification
More informationSpecial comment. (inferior vena cava filter, IVCF) Mobin-Uddin % [4] 1 IVCF
340 Special comment ; ; ; :R543.6 :A :1008-794X(2011)-05-0340-05 The consensus among Chinese interventional experts on the standard of inferior vena cava filter insertion and retrieval Academic Group of
More informationMeissner MH, Gloviczki P, Comerota AJ, Dalsing MC, Eklof BG, Gillespie DL, et al. J Vasc Surg. 2012;55:
Early thrombus removal strategies for acute deep venous thrombosis: Clinical Practice Guidelines of the Society for Vascular Surgery and the American Venous Forum Meissner MH, Gloviczki P, Comerota AJ,
More informationComplex Iliocaval Reconstruction PNEC. Seattle WA. Bill Marston MD Professor, Div of Vascular Surgery University of N.
Complex Iliocaval Reconstruction 2017 PNEC. Seattle WA Bill Marston MD Professor, Div of Vascular Surgery University of N. Carolina DISCLOSURES William Marston, MD Consultant/Advisory Board: Veniti, Cardinal
More informationUse of EKOS Catheter in the management of Venous Mr. Manoj Niverthi, Mr. Sarang Pujari, and Ms. Nupur Dandavate, The GTF Group
Use of EKOS Catheter in the management of Venous Thromboembolism @ Mr. Manoj Niverthi, Mr. Sarang Pujari, and Ms. Nupur Dandavate, The GTF Group Introduction Georgia Thrombosis Forum (GTF, www.gtfonline.net)
More informationORIGINAL INVESTIGATION. Indications, Complications, and Management of Inferior Vena Cava Filters
LESS IS MORE ORIGINAL INVESTIGATION Indications, Complications, and Management of Inferior Vena Cava Filters The Experience in 952 Patients at an Academic Hospital With a Level I Trauma Center Shayna Sarosiek,
More informationChronic Iliocaval Venous Occlusive Disease
none Chronic Iliocaval Venous Occlusive Disease David Rigberg, M.D. Clinical Professor of Surgery Division of Vascular Surgery University of California Los Angeles Chronic Venous Occlusive Disease Chronic
More informationInferior Vena Cava Filter Migration to the Right Ventricle: A Case Report and Review of Filter Migration and Misdeployment
Elmer Press Case Report Inferior Vena Cava Filter Migration to the Right Ventricle: A Case Report and Review of Filter Migration and Misdeployment Jason Dreyer a, d, Ketul Patel b, Huma Shujaat b, Michael
More informationVenous stent experience in Arnsberg Michael K. W. Lichtenberg MD, FESC
Venous stent experience in Arnsberg Michael K. W. Lichtenberg MD, FESC IMPORTANT INFORMATION: These materials are intended to describe common clinical considerations and procedural steps for the on-label
More informationPercutaneously Inserted AngioVac Suction Thrombectomy for the Treatment of Filter-Related. Iliocaval Thrombosis
Percutaneously Inserted AngioVac Suction Thrombectomy for the Treatment of Filter-Related Iliocaval Thrombosis Faiz D. Francis, DO; Gianvito Salerno, MD; Sabbah D. Butty, MD Abstract In the setting of
More informationVENOUS THROMBOEMBOLISM: DURATION OF TREATMENT
VENOUS THROMBOEMBOLISM: DURATION OF TREATMENT OBJECTIVE: To provide guidance on the recommended duration of anticoagulant therapy for venous thromboembolism (VTE). BACKGROUND: Recurrent episodes of VTE
More informationDEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service
M AY. 6. 2011 10:37 A M F D A - C D R H - O D E - P M O N O. 4147 P. 1 DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration 10903 New Hampshire Avenue Document Control
More informationEKOS. Interventional Vascular 3 February, Imagine where we can go.
EKOS Interventional Vascular 3 February, 2015 Imagine where we can go. Forward-looking statement This presentation and information communicated verbally to you may contain certain projections and other
More informationStraub Endovascular System &
Straub Endovascular System & S t r a u b E n d o v a s c u l a r To o l s Straub Endovascular System Effective debulking in occluded arteries and veins Effective debulking in many indications Rotarex
More informationComplications of inferior vena cava filters
Review Article Complications of inferior vena cava filters Simer Grewal, Murthy R. Chamarthy, Sanjeeva P. Kalva Department of Radiology, Division of Interventional Radiology, University of Texas Southwestern
More informationThrombosis & Hemostasis Summit of North America 2016Apr16. IVC Filters
Thrombosis & Hemostasis Summit of North America 2016Apr16 IVC Filters Bill Geerts, MD, FRCPC Thromboembolism Consultant, Sunnybrook HSC Professor of Medicine, University of Toronto National Lead, VTE Prevention,
More informationVersatility and Proven Safety
Versatility and Proven Safety Indicated for: Temporary or Permanent placement Standard or Over-The-Wire Delivery Jugular, Femoral, Antecubital, and Popliteal Access > Proven Safety Initial Clinical Trial
More informationVenous thrombosis is common and often occurs spontaneously, but it also frequently accompanies medical and surgical conditions, both in the community
Venous Thrombosis Venous Thrombosis It occurs mainly in the deep veins of the leg (deep vein thrombosis, DVT), from which parts of the clot frequently embolize to the lungs (pulmonary embolism, PE). Fewer
More informationIntroduction. Case CASE REPORTS ABSTRACT
CASE REPORTS Arrhythmia 2015;16(4):226-231 doi: http://dx.doi.org/10.18501/arrhythmia.2015.038 Massive Deep Vein Thrombosis Underlying Unexpected Iliac Vein Compression Syndrome (May-Thurner Syndrome)
More informationRisk factors for DVT. Venous thrombosis & pulmonary embolism. Anticoagulation (cont d) Diagnosis 1/5/2018. Ahmed Mahmoud, MD
Risk factors for DVT Venous thrombosis & pulmonary embolism Ahmed Mahmoud, MD Surgery ; post op especially for long cases, pelvic operations (THR), Trauma ; long bone fractures, pelvic fractures (posterior
More informationVenous thrombosis & pulmonary embolism. Ahmed Mahmoud, MD
Venous thrombosis & pulmonary embolism Ahmed Mahmoud, MD Risk factors for DVT Surgery ; post op especially for long cases, pelvic operations (THR), Trauma ; long bone fractures, pelvic fractures (posterior
More informationVIVO-EU Results: Prospective European Study of the Zilver Vena TM Venous Stent in the Treatment of Symptomatic Iliofemoral Venous Outflow Obstruction
VIVO-EU Results: Prospective European Study of the Zilver Vena TM Venous Stent in the Treatment of Symptomatic Iliofemoral Venous Outflow Obstruction Gerard J O Sullivan, M.D. and Jennifer McCann-Brown,
More informationFrom the Society for Vascular Surgery
From the Society for Vascular Surgery Role of prophylactic temporary inferior vena cava filters placed at the ICU bedside under intravascular ultrasound guidance in patients with multiple trauma David
More informationVIRTUS: Trial Design and Primary Endpoint Results
VIRTUS: Trial Design and Primary Endpoint Results Mahmood K. Razavi, MD St. Joseph Cardiac and Vascular Center Orange, CA, USA IMPORTANT INFORMATION: These materials are intended to describe common clinical
More informationHandbook for Venous Thromboembolism
Handbook for Venous Thromboembolism Gregory Piazza Benjamin Hohlfelder Samuel Z. Goldhaber Handbook for Venous Thromboembolism Gregory Piazza Cardiovascular Division Harvard Medical School Brigham and
More informationUltrasound-enhanced, catheter-directed thrombolysis for pulmonary embolism
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE Interventional procedure consultation document Ultrasound-enhanced, catheter-directed thrombolysis for pulmonary embolism A pulmonary embolism (PE) is
More informationNOTE: Deep Vein Thrombosis (DVT) Risk Factors
Deep Vein Thrombosis (DVT) Deep Vein Thrombosis (DVT) is the formation of a blood clot, known as a thrombus, in the deep leg vein. It is a very serious condition that can cause permanent damage to the
More informationDeep Vein Thrombosis and Pulmonary Embolism: Patient Information
Deep Vein Thrombosis and Pulmonary Embolism: Patient Information A Deep Vein Thrombosis (DVT) and a Pulmonary Embolism (PE) are both disorders of unwanted blood clotting. Unwanted blood clots can occur
More information2013 Coding Changes. Diagnostic Radiology. Nuclear Medicine
2013 Coding Changes The principal coding changes affecting Radiologists in 2013 occur in the Interventional Radiology Section of the AMA/CPT Manual. As in the past, we continue to see the Relative Update
More informationPROGNOSIS AND SURVIVAL
CANCER ASSOCIATED THROMBOSIS PROGNOSIS AND SURVIVAL Since French internist Armand Trousseau reported the occurrence of mysterious thrombotic disorders in cancer patients in the mid-19th century, the link
More informationA A U
PVD Venous AUC Rating Sheet 2nd Round 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 Median I NI MADM Rating Agree Disagree Upper Extremity Venous Evaluation Table 1. Venous Duplex of the Upper Extremities for Patency
More informationPatients with suspected DVT of the lower limb how to exam the patient
Patients with suspected DVT of the lower limb how to exam the patient Johannes Godt Dep. of Radiology and Nuclear Medicine Oslo University Hospital Ullevål NORDTER 2015, Oslo Content Anatomy and pathophysiology
More informationMabel Labrada, MD Miami VA Medical Center
Mabel Labrada, MD Miami VA Medical Center *1-Treatment for acute DVT with underlying malignancy is for 3 months. *2-Treatment of provoked acute proximal DVT can be stopped after 3months of treatment and
More informationPulmonary Emboli without Leg Symptoms, May-Thurner syndrome. Case Report and Review
ISPUB.COM The Internet Journal of Internal Medicine Volume 9 Number 2 Pulmonary Emboli without Leg Symptoms, May-Thurner syndrome. Case Report and Review A Hamo, M Alyaseen, F Alkhankan, T Gress Citation
More informationComplex Retrieval of Embedded Inferior Vena Cava Filters in Interventional Radiology
Transcript Details This is a transcript of an educational program accessible on the ReachMD network. Details about the program and additional media formats for the program are accessible by visiting: https://reachmd.com/programs/medical-breakthroughs-from-penn-medicine/complex-retrievalembedded-inferior-vena-cava-filters-interventional-radiology/7838/
More informationDVT - initial management NSCCG
Background information Information resources for patients and carers Updates to this care map Synonyms Below knee DVT and bleeding risks Patient with confirmed DVT Scan confirms superficial thrombophlebitis
More informationPulmonary Embolism. Pulmonary Embolism. Pulmonary Embolism. PE - Clinical
Pulmonary embolus - a practical approach to investigation and treatment Sam Janes Wellcome Senior Fellow and Respiratory Physician, University College London Background Diagnosis Treatment Common: 50 cases
More informationPULMONARY EMBOLISM (PE): DIAGNOSIS AND TREATMENT
PULMONARY EMBOLISM (PE): DIAGNOSIS AND TREATMENT OBJECTIVE: To provide a diagnostic algorithm and treatment options for patients with acute pulmonary embolism (PE). BACKGROUND: Venous thromboembolism (VTE)
More informationEpidermiology Early pulmonary embolism
Epidermiology Early pulmonary embolism Sitang Nirattisaikul Faculty of Medicine, Prince of Songkla University 3 rd most common cause of cardiovascular death in the United States, following ischemic heart
More informationDiagnosis and Management of Femoral Access Site Complications IV: Novel Techniques for Endovascular Rescue
Diagnosis and Management of Femoral Access Site Complications IV: Novel Techniques for Endovascular Rescue Robert M. Bersin, M.D. Director, Endovascular Services Seattle Cardiology and the Cardiovascular
More informationMedical Patients: A Population at Risk
Case Vignette A 68-year-old woman with obesity was admitted to the Medical Service with COPD and pneumonia and was treated with oral corticosteroids, bronchodilators, and antibiotics. She responded well
More informationVenous interventions in DVT
Venous interventions in DVT Sriram Narayanan Chief of Vascular and Endovascular Surgery, Tan Tock Seng Hospital A/Prof of Surgery, National University of Singapore ANTI-COAGULATION LMWH Warfarin x 6m Acute
More informationNot all Leg DVT s are the Same: Which Patients Benefit from Interventional Therapy? Case 1:
12/16/2015 Not all Leg DVT s are the Same: Which Patients Benefit from Interventional Therapy? Constantino S.Peña, FSIR, FSCCT, FAHA Interventional Radiologist Medical Director, Vascular Imaging Miami
More informationThe hallmark of percutaneous thrombus management
Treating Venous Thromboembolism Without Lytic Medications What the present and the near future will bring in terms of techniques and devices to remove venous thrombus. BY CONSTANTINO S. PEÑA, MD; RIPAL
More informationIntroduction What Causes Peripheral Vascular Disease? How Do Doctors Treat Peripheral Vascular Disease?... 9
Patient Information Table of Contents Introduction... 3 What is Peripheral Vascular Disease?... 5 What Are Some of the Symptoms of Peripheral Vascular Disease?... 7 What Causes Peripheral Vascular Disease?...
More informationA rare case of May-Thurner-like syndrome in an elderly lady
CASE REPORT A rare case of May-Thurner-like syndrome in an elderly lady Chris Pui Yan Yee 1, Kapil Sahnan 2, Robert Hywel Thomas 1, Kaji Sritharan 1 1. Department of Vascular Surgery, St Mary's Hospital,
More informationVenous Thrombosis. Magnitude of the Problem. DVT 2 Million PE 600,000. Death 60,000. Estimated Cost of VTE Care $1.5 Billion/year.
Venous Thrombosis Magnitude of the Problem DVT 2 Million Postthrombotic Syndrome 800,000 PE 600,000 Death 60,000 Silent PE 1 Million Pulmonary Hypertension 30,000 Estimated Cost of VTE Care $1.5 Billion/year
More informationDOPPLER ULTRASOUND OF DEEP VENOUS THROMBOSIS
TOKUDA HOSPITAL SOFIA DOPPLER ULTRASOUND OF DEEP VENOUS THROMBOSIS MILENA STANEVA, MD, PhD Department of vascular surgery and angiology Venous thromboembolic disease continues to cause significant morbidity
More informationDEEP VEIN THROMBOSIS (DVT): TREATMENT
DEEP VEIN THROMBOSIS (DVT): TREATMENT OBJECTIVE: To provide an evidence-based approach to treatment of patients presenting with deep vein thrombosis (DVT). BACKGROUND: An estimated 45,000 patients in Canada
More informationVisceral aneurysm. Diagnosis and Interventions M.NEDEVSKA
Visceral aneurysm Diagnosis and Interventions M.NEDEVSKA History 1953 De Bakeyand Cooley Visceral aneurysm VAAs rare, reported incidence of 0.01 to 0.2% on routine autopsies. Clinically important Potentially
More informationDuplex ultrasound is first-line imaging for all
Our Protocol for Transabdominal Pelvic Vein Duplex Ultrasound A summary of s protocol for pelvic vein duplex ultrasonography, including equipment, patient positioning, ultrasound settings, and technique.
More information(This is a sample cover image for this issue. The actual cover is not yet available at this time.)
(This is a sample cover image for this issue. The actual cover is not yet available at this time.) This is an open access article which appeared in a journal published by Elsevier. This article is free
More informationCase-based topics to touch on Beware of devices that sit in veins. Asymptomatic PE management conundrum. nd Should we be testing for hypercoagulabilit
SMALL FEEDINGS IN VENOUS THROMBOEMBOLISM ACP CHAPTER MEETING TURF VALLEY, FEBRUARY, 2012 Daniel J. Brotman, MD, FACP, FHM Director, Hospitalist Program, Johns Hopkins Hospital Associate Professor of Medicine
More informationCOMMITTEE FOR PROPRIETARY MEDICINAL PRODUCTS (CPMP)
The European Agency for the Evaluation of Medicinal Products Evaluation of Medicines for Human Use London, 16 December 1999 COMMITTEE FOR PROPRIETARY MEDICINAL PRODUCTS (CPMP) NOTE FOR GUIDANCE ON CLINICAL
More informationIntroduction 3. What is Peripheral Vascular Disease? 5. What Are Some of the Symptoms of Peripheral Vascular Disease? 6
Patient Information Table of Contents Introduction 3 What is Peripheral Vascular Disease? 5 What Are Some of the Symptoms of Peripheral Vascular Disease? 6 What Causes Peripheral Vascular Disease? 7 How
More informationCase 37 Clinical Presentation
Case 37 73 Clinical Presentation The patient is a 62-year-old woman with gastrointestinal (GI) bleeding. 74 RadCases Interventional Radiology Imaging Findings () Image from a selective digital subtraction
More information